Press Releases

Company Press Releases

For additional media information contact:
Arthur J. Shannon, Vice President, Investor Relations and Communication
ajshannon@perrigo.com
269-686-1709(direct)
269-673-9128 (fax)

Daniel B. Willard, Manager, Investor Relations and Communication
dbwillard@perrigo.com
269-686-1597 (direct)
269-673-9128 (fax)

Archive: 2008 |2007 |2006 | 2005 | 2004

2009

Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
February 2, 2010
See Attachment

Perrigo Announces Quarterly Dividend
Janaury 27, 2010
See Attachment

Perrigo Will Release Second Quarter Fiscal Year 2010 Results on February 2, 2010
Janaury 19, 2010
See Attachment

Perrigo to Present at the 28th Annual J.P. Morgan Healthcare Conference
Janaury 7, 2010
See Attachment

Perrigo Launches Labeling Initiatives to Identify Gluten-free Products
December 7, 2009
See Attachment

Perrigo To Present at the Credit Suisse 18th Annual Health Care Conference
November 9, 2009
See Attachment

Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
November 2, 2009
See Attachment

Perrigo Divests Israel Cosmetics Business for 205 Million Israeli Shekels
November 2, 2009
See Attachment

Perrigo Company Announces Dividend Increase
October 29, 2009
See Attachment

Perrigo Will Release First Quarter FY 2010 Results on November 2, 2009
October 19, 2009
See Attachment

Perrigo Announces Dismissal of Duac® Patent Litigation
October 19, 2009
See Attachment

Perrigo Confirms Filing for Generic Version of Men's Rogaine® Foam
October 13, 2009
See Attachment

Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
October 6, 2009
See Attachment

Perrigo Acquires ANDA for Generic Version Duac® Gel From KV Pharmaceutical
September 21, 2009
See Attachment

Perrigo Company To Host Investor Day
September 21, 2009
See Attachment

Perrigo Reports Record Sales, Earnings and Cash Flow from Operations for Fiscal 2009
August 18, 2009
See Attachment

Perrigo Company Announces Quarterly Dividend
August 13, 2009
See Attachment

Perrigo Will Release Fiscal Year 2009 Results on August 18, 2009
August 4, 2009
See Attachment

Perrigo Announces FDA Approval for Generic Version of Nasacort ® AQ
August 3, 2009
See Attachment

Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
July 13, 2009
See Attachment

Perrigo Confirms That Its Partner Synthon Has Filed For Generic Version of Xyzal®
June 24, 2009
See Attachment

Perrigo to Present at the Deutsche Bank 34th Annual Health Care Conference
May 15, 2009
See Attachment

Perrigo to Present at the Bank of America & Merrill Lynch 2009 Healthcare Conference
May 12, 2009
See Attachment

Perrigo Reports Record Third Quarter
May 7, 2009
See Attachment

Perrigo Company Announces Quarterly Dividend
May 6, 2009
See Attachment

Perrigo Will Release Third Quarter Fiscal Year 2009 Results on May 7, 2009
April 22, 2009
See Attachment

Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
March 24, 2009
See Attachment

Perrigo and Partner Cobrek Confirm Filing for Generic Version of Evoclin(R)
March 17, 2009
See Attachment

Perrigo Begins Shipments of Ibuprofen PM
February 20, 2009
See Attachment

Perrigo Reports Record Second Quarter Sales
February 3, 2009
See Attachment

Perrigo Announces Quarterly Dividend
January 28, 2009
See Attachment

Perrigo Will Release Second Quarter Fiscal Year 2009 Results on Feb. 3, 2009
January 21, 2009
See Attachment

Perrigo to Present at the 27th Annual JPMorgan Healthcare Conference
January 7, 2009
See Attachment

We have provided our Press Releases in Adobe® Portable Document Format.

1. To view a Press Release, you need to have

Adobe Acrobat Reader

o Click here to go to the Adobe site to download the Adobe® Acrobat software.

o When the download is complete, you will need to install the software on your computer.

2. If your computer already has the Adobe® Acrobat Reader, or you have completed the steps above, click on the Press Release you want to read.